The top 100 stock
market authors
selected for publication
market authors
selected for publication
Saul Sterman » Comments » CUTR
More on CUTR by Saul Sterman
Comments by Ticker
109 comments
Rating: -1
(1 is 
-
2 
)
-
2 )
-
The Seeking Alpha 100
See all
Seeking Alpha 100 » -
Fastest Climbers
Authors with the largestSee all
increase in followers
in the last 7 days
Fastest Climbers » -
Top Commenters
Top commenters,See all
as ranked by their peers
Top Commenters » -
Top Instabloggers
The 100 most active
Instabloggers.-
1
David Fry
-
2
TraderMark
-
3
Don Dion
-
4
Cliff Wachtel
-
5
Mike Havrilla
Top Instabloggers » -
1
-
Top StockTalkers
TopSee all
StockTalkers.
Top StockTalkers »
Palomar Technologies' Patent Play [View article]
The quotes above from Paul Weiner are confirmed in writing as of 9/14/06. If your conclusion is different than mine, please show me how you interpret the statements.
Note that I am not taking sides over here. I am not addressing the issue of whether or not the suit will succeed. Syneron’s silence is deafening. I waited in vain more than a reasonable amount of time for a response from CLZR and ELOS. I had to try and balance the article to the best of my ability without the assistance of David or Judith (Syneron).
I know that you are heavily invested in ELOS and I wish I could provide you with more clarity. Frankly, I have no idea how the markets will interpret this development. CrossProfit has not been able to post an evaluation line for CLZR, PMTI and ELOS because of the patent issue. It could be a lot more painful than we think – both ways.